<?xml version="1.0" encoding="UTF-8"?>
<p class="p">No changes in hematology and clinical chemistry parameters were observed in dams in the AOCED groups when compared to those in the control at the completion of the lactation phase (
 <xref ref-type="supplementary-material" rid="pone.0217794.s002" class="xref">S2</xref> and 
 <xref ref-type="supplementary-material" rid="pone.0217794.s003" class="xref">S3</xref> Tables). Reduction of the mean cholesterol level was noted in the AOCED high dose group but was not considered adverse.
</p>
